Table 4 Clinical cure rates by diagnosis at test-of-cure visit (ME population)
Tigecycline | Imipenem/cilastatin | Difference (Tigecycline-Imipenem/cilastatin) | |||
|---|---|---|---|---|---|
Diagnosis | N | % (95% CI) | N | % (95% CI) | % (95% CI) |
Complicated appendicitis | 40/46 | 87.0 (73.7, 95.1) | 45/45 | 100 (92.1, 100.0) | -13.0 (-27.0, -0.6) |
Complicated cholecystitis | 2/2 | 100.0 (15.8, 100.0) | 0/0 | NA | NA |
Peritonitis | 2/3 | 66.7 (9.4, 99.2) | 2/3 | 66.7 (9.4, 99.2) | 0.0 (-62.7, 62.7) |
Gastric/duodenal perforation | 1/1 | 100.0 (2.5, 100.0) | 0/0 | NA | NA |